data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
NeuBase Therapeutics
(NASDAQ:NBSE)
0.85
-0.04[-4.49%]
At close: Jun 24
0.81
-0.0400[-4.71%]
After Hours: 4:52PM EDT
Day High/Low0.79 - 0.98
52 Week High/Low0.79 - 5.45
Open / Close0.91 / 0.85
Float / Outstanding31.7M / 32.3M
Vol / Avg.63.5K / 66.4K
Mkt Cap27.4M
P/E-
50d Avg. Price1.08
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float31.7M

NeuBase Therapeutics (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics (NASDAQ: NBSE)

Day High/Low0.79 - 0.98
52 Week High/Low0.79 - 5.45
Open / Close0.91 / 0.85
Float / Outstanding31.7M / 32.3M
Vol / Avg.63.5K / 66.4K
Mkt Cap27.4M
P/E-
50d Avg. Price1.08
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float31.7M
Benzinga - May 31, 2022, 6:26AM
Benzinga - May 13, 2022, 7:39AM
Benzinga - May 12, 2022, 5:18PM
Benzinga - Mar 14, 2022, 9:41AM
Benzinga - Jan 10, 2022, 4:02PM
Benzinga - Dec 23, 2021, 4:02PM
Benzinga - Nov 24, 2021, 12:18PM
Benzinga - Nov 24, 2021, 11:21AM
Benzinga - Sep 28, 2021, 4:14PM
Benzinga - Aug 12, 2021, 4:21PM
load more
Sector: Health Care.Industry: Biotechnology
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q2 2022Est.ActualSurprise
EPS-0.300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

NeuBase Therapeutics Questions & Answers

Q
How do I buy NeuBase Therapeutics (NBSE) stock?
A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are NeuBase Therapeutics's (NBSE) competitors?
Q
What is the target price for NeuBase Therapeutics (NBSE) stock?
A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by HC Wainwright & Co. on Tuesday, May 31, 2022. The analyst firm set a price target for 10.00 expecting NBSE to rise to within 12 months (a possible 1076.47% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for NeuBase Therapeutics (NBSE)?
A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated June 24, 2022, 8:00 PM UTC.

Q
Does NeuBase Therapeutics (NBSE) pay a dividend?
A

There are no upcoming dividends for NeuBase Therapeutics.

Q
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
A

NeuBase Therapeutics’s Q3 earnings are confirmed for Thursday, August 11, 2022.

Q
Is NeuBase Therapeutics (NBSE) going to split?
A

There is no upcoming split for NeuBase Therapeutics.

Q
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.